External validation analysis found that the modest cognitive improvements from U.S. POINTER's structured lifestyle intervention translate to remarkably small reductions in dementia progression risk. When the +0.029 standard deviation annual cognitive slope benefit was mapped onto three independent cohorts (ADNI, A4, LEARN totaling over 1,900 participants), hazard ratios for progression to mild cognitive impairment or dementia ranged from 0.972 to 0.998, representing absolute risk reductions of just 0.06-0.31 percentage points over five years. The most favorable scenario would prevent one case of cognitive decline for every 175-1,667 people treated. This translation reveals a concerning gap between statistically significant cognitive test improvements and meaningful clinical outcomes. While lifestyle interventions remain valuable for overall health, these findings suggest the cognitive benefits may be too modest to substantially delay dementia onset at the population level. The economic implications are sobering, requiring extremely low intervention costs to achieve cost-effectiveness. As a preprint awaiting peer review, these results require confirmation, but they highlight the challenge of translating small cognitive gains into clinically meaningful dementia prevention.